Stay updated on Faricimab in Diabetic Macular Edema Clinical Trial
Sign up to get notified when there's something new on the Faricimab in Diabetic Macular Edema Clinical Trial page.

Latest updates to the Faricimab in Diabetic Macular Edema Clinical Trial page
- Check2 days agoChange DetectedA new revision tag v3.6.1 has been introduced, replacing v3.6.0. This indicates a small update to the site's underlying version without altering visible content or user-facing features.SummaryDifference0.0%

- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedRecruitment status updated to closed and new help/navigation links added; revision version bumped to v3.6.0. A new Li X et al. publication on the China RHINE subpopulation was added, while an older Li X et al. citation and v3.5.5 reference were removed.SummaryDifference0.2%

- Check23 days agoChange DetectedThe revision label in the page footer changed from v3.5.4 to v3.5.5, reflecting an update to the site's page template/version.SummaryDifference0.0%

- Check38 days agoChange DetectedRevision label updated from v3.5.3 to v3.5.4, indicating a new documentation version. This change is a metadata update and does not alter the study details or page structure.SummaryDifference0.0%

- Check45 days agoChange DetectedTwo new publications were added to the Publications list, introducing new author names and article details, and one publication was removed to update the study's bibliographic references for RHINE and YOSEMITE results.SummaryDifference0.0%

- Check52 days agoChange DetectedTaoyuan District, Taiwan, 333 was removed as a study site entry. Taoyuan, Taiwan, 333 was added to the list of study locations.SummaryDifference0.0%

Stay in the know with updates to Faricimab in Diabetic Macular Edema Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Faricimab in Diabetic Macular Edema Clinical Trial page.